Science 37 Holdings Stock Beta
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
Science 37 Holdings fundamentals help investors to digest information that contributes to Science 37's financial success or failures. It also enables traders to predict the movement of Science Stock. The fundamental analysis module provides a way to measure Science 37's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Science 37 stock.
Science |
Science 37 Holdings Company Beta Analysis
Science 37's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Science 37 Beta | 0.56 |
Most of Science 37's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Science 37 Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, Science 37 Holdings has a Beta of 0.565. This is 34.3% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Science Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Science 37's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Science 37 could also be used in its relative valuation, which is a method of valuing Science 37 by comparing valuation metrics of similar companies.Science 37 is currently under evaluation in beta category among its peers.
As returns on the market increase, Science 37's returns are expected to increase less than the market. However, during the bear market, the loss of holding Science 37 is expected to be smaller as well.
Science Fundamentals
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.07) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | (21.22 M) | |||
| Shares Outstanding | 6.03 M | |||
| Shares Owned By Insiders | 16.89 % | |||
| Shares Owned By Institutions | 52.18 % | |||
| Number Of Shares Shorted | 13.83 K | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 0.58 X | |||
| Revenue | 60.26 M | |||
| Gross Profit | 20.07 M | |||
| EBITDA | (59.86 M) | |||
| Net Income | (124.65 M) | |||
| Cash And Equivalents | 130.24 M | |||
| Cash Per Share | 1.12 X | |||
| Total Debt | 1.32 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 6.32 X | |||
| Book Value Per Share | 8.69 X | |||
| Cash Flow From Operations | (48.19 M) | |||
| Short Ratio | 0.22 X | |||
| Earnings Per Share | (21.40) X | |||
| Target Price | 13.83 | |||
| Number Of Employees | 460 | |||
| Beta | 0.56 | |||
| Market Capitalization | 34.66 M | |||
| Total Asset | 126.45 M | |||
| Retained Earnings | (253.07 M) | |||
| Working Capital | 103.03 M | |||
| Z Score | 12.82 | |||
| Net Asset | 126.45 M |
About Science 37 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Science 37 Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Science 37 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Science 37 Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |